We can help you solve company communication.
Simplify your workflow in minutes.
Already have an account? Log in.
Don't have an account yet? Sign up.
Start delivering personalised medicine insights at scale with Vitae Evidence.
Follow industry trends, powerful insights, live-event learning and more through our active blog library.
We're here to help you better understand and use Vitae Evidence.
Getting Started, Release notes and Product Guides
Read more about our take on these once-in-a-generation opportunities.
2022-11-06
Over three years, I have seen our personalised medicine solution develop from resembling a "scientists garage" to the creation of two commercial companies.
2022-08-23
Senior Scientist at Vitae Evidence, Jimita Toraskar, offers her highlights from this year's Nordic Precision Medicine Forum.
2022-06-07
More patients will now have the opportunity to participate in clinical studies as part of the treatment. Read our views on how Digital Health can tackle trusts issues and ethical concerns.
2022-05-08
When medicines are unaffordable, they cannot save lives. Here are 7 ways to use the technology that our times deserve for faster equitable access.
2022-05-14
Norwegians must wait longer than Danes to access new medicines. We are looking into the impact on society and the hurdles to overcome.
2022-04-30
AI and Digital Health will enable new ways to evaluate the effectiveness of drugs, for faster equitable access to personalised medicine.
2021-02-18
Despite many translational barriers, connecting the molecular world to the clinical world and vice versa will undoubtedly benefit human health in the near future.
In this post, we dive into how Digital Health will contribute to increased opportunities for patients to participate in clinical trials.
What does it take to comply? When is it the right time? We tell you our approach and lessons learned.
What is special about the informed consent for personalised medicine? and what is the proper way to collect it? We tell you our approach and lessons learned.
This is the challenge that we decided to address. We'll tell you all about it in this post.
Here is how we are going to contribute to the “Action Plan for Clinical Studies (2021-2025)”, recently released in Norway by the Ministry of Health and Care Services.
We are taking an active role in CONNECT, the Norwegian Precision Cancer Medicine Implementation Consortium.
2021-06-11
From us to your inbox weekly.
